Oestrogen-only menopausal therapy 'ups risk of GORD'
Given that serious complications are also increased, it would be prudent for prescribers to consider alternative therapy, researchers say
Postmenopausal women prescribed oestrogen-only menopausal hormone therapy are at increased risk of gastro-oesophageal reflux disease and complications including oesophageal stricture, a large analysis shows.
US researchers say their results suggest a need for consideration of alternatives, such as progesterone-only therapy, in patients who already have reflux-related symptoms.
Drawing upon data from more than one million postmenopausal women aged 55 and over, the authors investigated the relationship between
